These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 25024761)

  • 1. A distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records.
    Weng C; Li Y; Ryan P; Zhang Y; Liu F; Gao J; Bigger JT; Hripcsak G
    Appl Clin Inform; 2014; 5(2):463-79. PubMed ID: 25024761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Use of Mobile Personal Health Records for Hemoglobin A1c Regulation in Patients With Diabetes: Retrospective Observational Study.
    Seo D; Park YR; Lee Y; Kim JY; Park JY; Lee JH
    J Med Internet Res; 2020 Jun; 22(6):e15372. PubMed ID: 32484447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing and Contrasting A Priori and A Posteriori Generalizability Assessment of Clinical Trials on Type 2 Diabetes Mellitus.
    He Z; Gonzalez-Izquierdo A; Denaxas S; Sura A; Guo Y; Hogan WR; Shenkman E; Bian J
    AMIA Annu Symp Proc; 2017; 2017():849-858. PubMed ID: 29854151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends of hemoglobin A1c testing.
    Pivovarov R; Albers DJ; Hripcsak G; Sepulveda JL; Elhadad N
    J Am Med Inform Assoc; 2014; 21(6):1038-44. PubMed ID: 24928176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate analysis of the population representativeness of related clinical studies.
    He Z; Ryan P; Hoxha J; Wang S; Carini S; Sim I; Weng C
    J Biomed Inform; 2016 Apr; 60():66-76. PubMed ID: 26820188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida.
    Tanton D; Duh MS; Lafeuille MH; Lefebvre P; Pilon D; Zhdanava M; Emond B; Inman D; Bailey RA
    Curr Med Res Opin; 2018 Jun; 34(6):1099-1115. PubMed ID: 29468896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials.
    Miotto R; Weng C
    J Am Med Inform Assoc; 2015 Apr; 22(e1):e141-50. PubMed ID: 25769682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
    Wysham CH; Pilon D; Ingham M; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Lefebvre P
    Endocr Pract; 2018 Mar; 24(3):273-287. PubMed ID: 29547044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult patient access to electronic health records.
    Ammenwerth E; Neyer S; Hörbst A; Mueller G; Siebert U; Schnell-Inderst P
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012707. PubMed ID: 33634854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemoglobin A1c--a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS).
    Manley S
    Clin Chem Lab Med; 2003 Sep; 41(9):1182-90. PubMed ID: 14598868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a Collaborative Care Model on Depressive Symptoms and Glycated Hemoglobin, Blood Pressure, and Serum Cholesterol Among Patients With Depression and Diabetes in India: The INDEPENDENT Randomized Clinical Trial.
    Ali MK; Chwastiak L; Poongothai S; Emmert-Fees KMF; Patel SA; Anjana RM; Sagar R; Shankar R; Sridhar GR; Kosuri M; Sosale AR; Sosale B; Rao D; Tandon N; Narayan KMV; Mohan V;
    JAMA; 2020 Aug; 324(7):651-662. PubMed ID: 32809002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacodynamic analysis of hemoglobin A1c-lowering effects by adding treatment of DPP-4 inhibitors (sitagliptin) in type 2 diabetes mellitus patients based on electronic medical records.
    Kakara M; Nomura H; Ezaki M; Fukae M; Hirota T; Matsubayashi S; Hirakawa M; Ieiri I
    J Diabetes Complications; 2016; 30(7):1282-6. PubMed ID: 27338508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world glycemic, blood pressure, and weight control in patients with type 2 diabetes mellitus treated with canagliflozin-an electronic health-record-based study.
    Lefebvre P; Pilon D; Robitaille MN; Lafeuille MH; Chow W; Pfeifer M; Duh MS
    Curr Med Res Opin; 2016 Jun; 32(6):1151-9. PubMed ID: 27115475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences Between Randomized Clinical Trial Participants and Real-World Empagliflozin Users and the Changes in Their Glycated Hemoglobin Levels.
    Munk NE; Knudsen JS; Pottegård A; Witte DR; Thomsen RW
    JAMA Netw Open; 2020 Feb; 3(2):e1920949. PubMed ID: 32031651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using electronic medical records analysis to investigate the effectiveness of lifestyle programs in real-world primary care is challenging: a case study in diabetes mellitus.
    Linmans JJ; Viechtbauer W; Koppenaal T; Spigt M; Knottnerus JA
    J Clin Epidemiol; 2012 Jul; 65(7):785-92. PubMed ID: 22560776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
    Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China.
    Bi Y; Zhu D; Cheng J; Zhu Y; Xu N; Cui S; Li W; Cheng X; Wang F; Hu Y; Shen S; Weng J
    Clin Ther; 2010 May; 32(5):973-83. PubMed ID: 20685506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OPPORTUNISTIC SCREENING FOR DIABETES AND PREDIABETES USING HEMOGLOBIN A1C IN AN URBAN PRIMARY CARE SETTING.
    Sohler N; Matti-Orozco B; Young E; Li X; Gregg EW; Ali MK; Bullard KM; Albu JB
    Endocr Pract; 2016 Feb; 22(2):143-50. PubMed ID: 26484404
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.